IHS, LLC, a Georgia-based healthcare acquisition and management firm, is thrilled to announce the acquisition of Atlanta Osteoarthritis Center LLC, a premier specialty clinic renowned for its excellence in regenerative knee care and chronic pain management. Located in Marietta, Georgia, this milestone acquisition marks a powerful expansion of IHS’s footprint in the Southeast and reflects its bold commitment to transforming healthcare delivery through innovation, expertise, and compassionate care.

The Atlanta Osteoarthritis Center has built a stellar reputation and currently serves a dedicated base of over 5,700 active patients. Its consistent patient growth, strong community presence, and well-established operations made it a perfect addition to the IHS portfolio.

Under the agreement, IHS has acquired the clinic’s full assets and will lead a seamless transition, supported by a hands-on management team focused on scaling operations, training staff, and elevating patient care to new heights.

Health Technology Insights: Santa Clara Health Plan Honors Top Healthcare Providers

An Exciting Future Ahead

This acquisition is just the beginning. IHS plans to introduce a dynamic suite of high-demand services, including:

  • Genicular Artery Embolization (GAE)
  • Genicular Ablation
  • Weight Loss & Nutritional Counseling
  • Hormone Replacement Therapy (HRT)
  • Stem Cell Therapy

These cutting-edge modalities will broaden patient access to advanced treatments and position the clinic as a leader in integrated musculoskeletal and wellness care.

Health Technology Insights: myTomorrows, Scout Partner for Global Trial Recruitment

“Our acquisition of the Atlanta OA Clinic is a major leap forward in our mission to reimagine specialty care,” said Warren Thomas, President and CEO of IHS, LLC. “With its exceptional foundation and patient loyalty, this clinic gives us a springboard to introduce transformative services that will benefit both patients and partners alike.”

Health Technology Insights: Flatiron Joins Veeva to Boost Oncology Research Efforts

To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com

Source – businesswire